Evidence map›Paper›PMID 41089801›Full record

ArticleReviews in cardiovascular medicine2025

Risk Factor Analysis and Predictive Nomogram for Heart Valve Calcification in Rheumatoid Arthritis.

Yiwei Lu, Xu Zhao, Xinyi He, Menglan Li, Qingqing Xie, Shiquan Shuai

Abstract read
In one paragraph

Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiwei LuDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.ORCID https://orcid.org/0009-0003-0506-1216
Xu ZhaoDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.
Xinyi HeDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.
Menglan LiDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.
Qingqing XieKey Laboratory of Inflammation and Immunity Nanchong, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.
Shiquan ShuaiDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Medical Research Center)-The Second Clinical Medical College of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.ORCID https://orcid.org/0009-0009-9085-3659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To develop a predictive model for cardiac valve calcification (CVC) in rheumatoid arthritis (RA) patients using a novel nomogram approach. Methods: We analyzed data from patients diagnosed with RA at the Department of Rheumatology and Immunology, Nanchong Central Hospital, between January 1, 2020, and October 31, 2023. Data were gathered on patient demographics, disease characteristics, laboratory tests, and imaging findings. Patients were randomly divided into a training set (n = 210) and a validation set (n = 140), in a ratio of 6:4, respectively. Least absolute shrinkage and selection operator (LASSO) regression was employed to identify risk predictors. Meanwhile, both single-factor and multi-factor logistic regression analyses were conducted to ascertain the risk factors associated with cardiac valve calcification. A predictive model was constructed using R software and validated through Bootstrap techniques. The performance of the model was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC), calibration curves, and decision curve analysis (DCA). Results: A total of 350 RA patients were included in the study, of whom 67 (19.1%) were diagnosed with CVC. Multivariate analysis identified several significant risk factors for CVC, including hypertension (odds ratio (OR) = 15.496, 95% confidence interval (CI): 4.373-54.916; Conclusion: The developed model can effectively identify RA patients at high risk for CVC. This tool provides a scientific basis for clinical decision-making and has significant potential for enhancing patient management and outcomes.

Indexed as

calcification of heart valvesprediction modelrheumatoid arthritis

Identifiers

PMID41089801
PMCPMC12516738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.